480 results on '"Gilmour, Jill"'
Search Results
2. Infection with HIV-1 subtype D among acutely infected Ugandans is associated with higher median concentration of cytokines compared to subtype A
3. Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans
4. Comprehensive epitope mapping using polyclonally expanded human CD8 T cells and a two-step ELISpot assay for testing large peptide libraries
5. Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection
6. Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort.
7. Reduced frequency of HIV superinfection in a high-risk cohort in Zambia
8. Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial
9. HLA-A*23 Is Associated With Lower Odds of Acute Retroviral Syndrome in Human Immunodeficiency Virus Type 1 Infection: A Multicenter Sub-Saharan African Study
10. Safety and Broad Immunogenicity of HIVconsvX Conserved Mosaic Candidate T-Cell Vaccines Vectored by ChAdOx1 and MVA in HIV-CORE 006: A Double-Blind, Randomized, Placebo-Controlled Phase 1 Trial in Healthy Adults Living Without HIV-1 in Eastern and Southern Africa
11. Elevated levels of inflammatory plasma biomarkers are associated with risk of HIV infection
12. Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa
13. Evaluating the Impact of Functional Genetic Variation on HIV-1 Control
14. Mosaic HIV-1 vaccination induces anti-viral CD8 + T cell functionality in the phase 1/2a clinical trial APPROACH
15. African-led health research and capacity building- is it working?
16. Establishment and implementation of a regional mucosal training program to facilitate multi-center collaboration in basic and clinical research in Eastern Africa
17. First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus–Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens
18. Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch
19. Oral Typhoid Vaccination With Live-Attenuated Salmonella Typhi Strain Ty21a Generates Ty21a-Responsive and Heterologous Influenza Virus–Responsive CD4 + and CD8 + T Cells at the Human Intestinal Mucosa
20. Control of HIV-1 replication in vitro by vaccine-induced human CD8+ T cells through conserved subdominant Pol epitopes
21. Broad HIV-1 inhibition in vitro by vaccine-elicited CD8+ T cells in African adults
22. Immunosuppression induced by ultraviolet irradiation and the role of urocanic acid
23. Canine distemper virus neutralization activity is low in human serum and it is sensitive to an amino acid substitution in the hemagglutinin protein
24. Cohort-Specific Peptide Reagents Broaden Depth and Breadth Estimates of the CD8 T Cell Response to HIV-1 Gag Potential T Cell Epitopes
25. Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses
26. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4⁺ T cells, and disease progression
27. Selection bias at the heterosexual HIV-1 transmission bottleneck
28. Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1
29. Dynamics of viremia in primary HIV-1 infection in Africans: Insights from analyses of host and viral correlates
30. Impact of pre-adapted HIV transmission
31. Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones
32. Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV‐1 positive patients with well‐estimated dates of seroconversion
33. Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa
34. CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus
35. Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of HIV-1 Vaccine Candidates
36. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
37. Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials
38. No Evidence for Association of β‐Defensin Genomic Copy Number with HIV Susceptibility, HIV Load during Clinical Latency, or Progression to AIDS
39. Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions
40. Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibition
41. Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects
42. Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans
43. Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006–2011)
44. Strengthening laboratory capacity for HIV vaccine clinical trials and epidemiological studies in Eastern and Southern Africa
45. Interleukin-21 Receptor Expression on CD8 T Cells: A Potential Biomarker of HIV-1 Disease State and Trajectory
46. Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial
47. Increased Frequency of Inter-Subtype HIV-1 Recombinants Identified by Near Full-Length Virus Sequencing in Rwandan Acute Transmission Cohorts
48. Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa
49. HIV TRANSMISSION: Selection bias at the heterosexual HIV-1 transmission bottleneck
50. Additional file 11 of Elevated levels of inflammatory plasma biomarkers are associated with risk of HIV infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.